## Clinical Assessment This patient presents with acute ischemic stroke within the thrombolytic window (90 minutes from symptom onset, well within the 4.5-hour window for IV thrombolysis). The clinical presentation is classic: sudden onset focal neurological deficits (facial droop, hemiparesis, aphasia) with no hemorrhage on CT head. **Key Point:** IV thrombolysis with alteplase (rt-PA) is the gold standard for acute ischemic stroke within 4.5 hours of symptom onset in eligible patients [cite:Harrison 21e Ch 435]. ## Eligibility Criteria Met - Time window: 90 minutes (well within 4.5 hours) - Non-contrast CT excludes hemorrhage - No contraindications evident (normal glucose, no seizure, no recent surgery) - Clear clinical stroke syndrome **High-Yield:** The standard dose of IV alteplase for acute ischemic stroke is **0.9 mg/kg** (maximum 90 mg), with 10% given as bolus over 1 minute and remainder over 60 minutes [cite:Stroke Guidelines 2019]. ## Why Other Options Are Suboptimal | Option | Why Incorrect | |--------|---------------| | Aspirin alone + observation | Delays definitive reperfusion therapy; aspirin is inferior to thrombolysis in acute phase | | CT angiography first | Adds delay; not required before thrombolysis in this clear-cut case; can be done post-thrombolysis if indicated | | Heparin anticoagulation | No evidence for acute phase; thrombolysis is superior; heparin may be considered post-thrombolysis | **Clinical Pearl:** The "door-to-needle" time should be <60 minutes for IV thrombolysis — every minute of delay increases morbidity and mortality. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.